KR100261044B1 - Nuecin cdna separated from bombyx mori - Google Patents

Nuecin cdna separated from bombyx mori Download PDF

Info

Publication number
KR100261044B1
KR100261044B1 KR1019970047219A KR19970047219A KR100261044B1 KR 100261044 B1 KR100261044 B1 KR 100261044B1 KR 1019970047219 A KR1019970047219 A KR 1019970047219A KR 19970047219 A KR19970047219 A KR 19970047219A KR 100261044 B1 KR100261044 B1 KR 100261044B1
Authority
KR
South Korea
Prior art keywords
nuecin
recombinant
silkworm
dna
protein
Prior art date
Application number
KR1019970047219A
Other languages
Korean (ko)
Other versions
KR19990025553A (en
Inventor
강석우
진병래
강석권
윤은영
김상현
김근영
Original Assignee
김동태
농촌진흥청
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 김동태, 농촌진흥청 filed Critical 김동태
Priority to KR1019970047219A priority Critical patent/KR100261044B1/en
Publication of KR19990025553A publication Critical patent/KR19990025553A/en
Application granted granted Critical
Publication of KR100261044B1 publication Critical patent/KR100261044B1/en

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86Viral vectors
    • C12N15/866Baculoviral vectors
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)

Abstract

PURPOSE: Provided is a cDNA of antimicrobial protein nuecin separated from Bombyx mori. And a recombinant antimicrobial protein nuecin is also provided which is effective on both gram positive and negative bacteria, so as to be applied to agricultural chemicals. CONSTITUTION: The cDNA of antimicrobial protein nuecin has the nucleotide sequence of figure (1) consisting of 852 bp and the amino acid sequence of figure (2) consisting of 214 amino acids. The expression vector pBacPAK8-nuecin shown in figure (3) contains the cDNA of antimicrobial protein nuecin. The recombinant virus vAc-nuecin is produced by transforming with the expression vector pBacPAK8-nuecin. The antimicrobial protein nuecin is produced by infecting Spodoptera frugiferda 9 with vAc-nuecin and collecting nuecin.

Description

집누에로부터 분리한 항세균성 단백질 유전자 누에신의CDNA와 그 재조합 단백질CDNA of antibacterial protein gene silkworm isolated from Korean silkworm and its recombinant protein

제1도는 누에신CDNA의 염기서열을 나타낸 것이고,1 shows the nucleotide sequence of silkworm C DNA,

제2도는 누에신CDNA 염기서열로부터 연역된 이미노산 서열을 나타낸 것이고,2 shows the imino acid sequence deduced from the silkworm C DNA sequence,

제3도는 누에신CDNA를 포함하고 있는 재조합 베큘로바이러스 발현용 전이벡터 제작 과정의 모식도를 나타낸 것이고,3 shows a schematic diagram of a process for preparing a transfection vector for expressing recombinant baculovirus containing silkworm C DNA,

제4도는 재조합 베큘로바이러스 누에신CDNA를 포함하고 있음을 확인하기 위해 재조합 바이러스 DNA를 서던 블랏 (Southern blot) 분석한 결과이고,4 is a result of Southern blot analysis of recombinant viral DNA to confirm that it contains recombinant baculovirus silkworm C DNA,

제5도는 재조합 베큘로바이러스에 의하여 곤충세포주(Sf21)에서 발현된 재조합 누에신의 12.5% SDS-플리아크릴아마이드 젤을 이용하여 단백질 전기영동 분석을 한 것이다.5 shows protein electrophoresis analysis using 12.5% SDS-polyacrylamide gel of recombinant silkworm expressed in insect cell line (Sf21) by recombinant baculovirus.

본 발명은 집누에 (Bombyx mori)로부터 분리한 새로운 항세균성 단백질 유전자 누에신의CDNA와 이를 곤충 베큘로바이러스 발현계를 이용하여 생산한 재조합 단백질에 관한 것이다.The present invention relates to C DNA of a new antibacterial protein gene silkworm isolated from Bombyx mori and recombinant protein produced using the insect baculovirus expression system.

곤충은 미생물이나 외부물질 등의 침입에 대한 생체 방어수단으로 식작용 (phagocytosis), 결절형성 (nodule formation), 캡슐형성 (encapsulation) 등으로 침입물질을 제거한 세포성 면역과 지방체와 혈구에서 단백질을 합성한 후 혈림프로 분비하여 미생물을 제거하는 체액성 면역을 가지고 있다 (Boman & Hultmark, Annu. Rev. Microbiol., 41, 103-216, 1987: Dunn, Annu, Rev. Entomol., 31, 321-329, 1986). 곤충 표피의 상처 또는 세균이나 리포폴리사카라이드 (lipopolysaccharide)등의 체강주입으로 면역유도한 산누에나방과 스크로피아잠 (Hyalophora cecropia)으로부터 세크로핀 (ceceoin), 라이소자임 (lysozyme), 헤모린 (hemolin) 및 아타신 (attacin) 등의 항세균 활성을 나타내는 단백질을 분리하였다. (Boman & Hultmark, Trends Biochem. Sci., 6, 306, 1981). 그밖의 면역과 관련된 다른 단백질로는 아피데신 (apidaecin), 디펜신 (defensin), 딥테리신 (diptericin), 하이판신 (hyphancin) 등이 보고되고 있다. (Casteels et al., EMBO J., 8, 2387-2391, 1989 : Lambert et al., Proc. Nat1. Aacad. Sci. U.S.A., 86, 262-266, 1989 : Dimardq et al., Eur j. Biochem., 171,17-22, 1988 : Park et al., Korean J. Entomol., 24,191-198. 1994). 이 중 아타신은 약 20~30 kDa의 분자량을 가지는 펩타이드로, 지금까지 보고된 6가지의 형태 중 4가지는 염기성, 2가지는 산성의 등전점을 나타낸다 (Dunn, Annu. Rev. Entomol., 31, 321-329, 1986). 산성 아타신은 19개 아미노산 신호 염기서열 (signal sequence)과 28개 아미노산 프로시퀀스 (prosequence)로 이루어졌고, 염기성 아타신은 17개 아미노산 신호 염기서열과 29개 아미노산 프로시퀀스로 구성되어 있으며, 전구체 형태의 프리프로아타신 (preproattacin) 은 소포체 (endoplasmic reticulum)로 수송된 후 (Simon & Blobel, Cell, 65, 371-380, 1991), 골지체 (golgi body)에서 2개의 염기성 잔기 (Arginine-Arginine)를 인식하는 효소에 의해 신호 펩타이드 (signal peptide)가 제거되어 성숙 아타신으로 전환되고 (Pfeffer & Rothman, Annu Raev. Biochem., 56, 829-852, 1987), 아타신 N-말단의 글루타민 (Glutamine)이 파이로글루타밀 (pyoglutamyl)로 전환되면서 혈림프로 분비되어 생물학적 활성을 나타낸다 (Gunne et al., Eur. J. Biochem., 187, 699-703, 1990). 한편, 세크로핀은 세균의 막을 파괴하는 작용을 하고, Sarcophaga peregrina(flesh fly)에서 분리된 아타신과 유사한 단백질인 사코톡신 투에이 (sarcotoxin 11A)는 세균의 세포벽 합성을 저해하는 작용을 함이 밝혀졌다(Ando & Natori, Biochmistry, 27, 1715-1721, 1988 : Kanai & Natori, Mol. Cell., 10, 6114-6122, 1990). 그리고 아타신은 세균 피막 단백질의 생합성을 저해하고 (Carlsson et al., infect. lmmuno., 59, 3040-3045, 1991), E. coli의 외막을 침해하여 세크로핀이나 라이소자임의 항세균 활성을 증진시키나, 그 항세균 활성이 그람 음성 세균에 국한되어져 있다(Engstrom et al., EMBO J., 3, 3347-3351, 1984). 또한 누에로부터 분리된 아타신 유사 펩타이드 Bmatt는CDNA의 크기가 846 bp로 보고되었으나 항세균 활성의 스펙트럼은 아직 보고되지 않았다 (Sugiyama, M. et al., Insect Biochem. Mol., 23, 385-392, 1995),Insects are a biological defense against invasion of microorganisms or foreign substances. Insects synthesize proteins from cellular immunity and fat and blood cells that remove invasive substances through phagocytosis, nodule formation, and encapsulation. And humoral immunity to secrete hemolymph to remove microorganisms (Boman & Hultmark, Annu. Rev. Microbiol., 41, 103-216, 1987: Dunn, Annu, Rev. Entomol., 31, 321-329 , 1986). Cecropin, lysozyme, and hemoline from wild silkworm moths and Hyalophora cecropia immunized with celiac injection of insect epidermal wounds or bacteria or lipopolysaccharides ) And proteins exhibiting antibacterial activity such as atacin were isolated. (Boman & Hultmark, Trends Biochem. Sci., 6, 306, 1981). Other proteins related to immunity have been reported, such as apidaecin, defensin, diptericin, and hypophancin. (Casteels et al., EMBO J., 8, 2387-2391, 1989: Lambert et al., Proc. Nat. Aacad. Sci. USA, 86, 262-266, 1989: Dimardq et al., Eur j. Biochem , 171, 17-22, 1988: Park et al., Korean J. Entomol., 24,191-198. 1994). Among these, atacin is a peptide having a molecular weight of about 20 to 30 kDa. Of the six forms reported so far, four have basic and two acidic isoelectric points (Dunn, Annu. Rev. Entomol., 31, 321- 329, 1986). Acidic atacin consists of 19 amino acid signal sequences and 28 amino acid sequences, and basic atacin consists of 17 amino acid signal sequences and 29 amino acid sequences, which form precursors Loatacin (preproattacin) is transported to the endoplasmic reticulum (Simon & Blobel, Cell, 65, 371-380, 1991), and the enzyme recognizes two basic residues (Arginine-Arginine) in the golgi body. Signal peptide is removed and converted to mature atacin (Pfeffer & Rothman, Annu Raev. Biochem., 56, 829-852, 1987), and the atacin N-terminal glutamine (pylutamine) It is converted into glutoglutamyl and secreted into hemolymph and exhibits biological activity (Gunne et al., Eur. J. Biochem., 187, 699-703, 1990). On the other hand, it is found that cecropin acts to destroy bacterial membranes, and sarcotoxin 11A, an attacin-like protein isolated from Sarcophaga peregrina (flesh fly), inhibits bacterial cell wall synthesis. (Ando & Natori, Biochmistry, 27, 1715-1721, 1988: Kanai & Natori, Mol. Cell., 10, 6114-6122, 1990). Atasin inhibits the biosynthesis of bacterial coat proteins (Carlsson et al., Infect. Lmmuno., 59, 3040-3045, 1991) and invades the outer membrane of E. coli to enhance the antibacterial activity of cecropin or lysozyme. However, its antibacterial activity is limited to Gram-negative bacteria (Engstrom et al., EMBO J., 3, 3347-3351, 1984). In addition, the atacin-like peptide Bmatt, isolated from silkworms, was reported to have a C DNA size of 846 bp but no antibacterial activity spectrum was reported yet (Sugiyama, M. et al., Insect Biochem. Mol., 23, 385-). 392, 1995),

아타신의 응용 연구로는 아타신 E 유전자 도입으로 사과나무의 병원세균인 Erwinia amylovora에 저항성을 나타내는 내병성 형질전환 식물체 생산을 하였으며, 비닐 하우스에서의 생물 검정에 성공한 바 있다(Norelli et al., Euohytica, 77, 123-128, 1994).Attacin's application research has led to the introduction of attacin E gene to produce a disease-resistant transgenic plant that is resistant to the erwinia amylovora, an apple tree pathogen, and has succeeded in bioassay in plastic houses (Norelli et al., Euohytica, 77, 123-128, 1994).

곤충의 항세균성 펩타이드는 내병성 형질 전환 식물체 창출에 이용될 수 있을 뿐 아니라 생물 농약으로도 가능하며, 또 그 구조가 간단하여 기존 합성 항생체를 대체할 수 있는 생물 신소재로서의 가치가 높다고 판단된다.Insect antibacterial peptides can be used not only for the creation of disease-resistant transgenic plants, but also as biological pesticides, and their simple structure makes them highly valuable as new biomaterials that can replace existing synthetic antibiotics.

따라서, 본 발명은 집누에 (Bombyx mori)로부터 새로운 항세균성 펩타이드 누에신CDNA를 분리하였으며 이를 곤충 베큘로바이러스 발현 벡터계를 이용하여 재조합 단백질을 생산하고 그람 음성 세균 뿐만 아니라 그람 양성 세균에도 항세균 활성 스팩트럼을 가짐을 밝힘으로서 이러한 항세균성 펩타이드를 내병성 형질전환 식물체 창출, 생물농약 및 생물 신소재 등으로 응용하기 위하여 제공하는데 그 목적이 있다.Therefore, the present invention isolated new antibacterial peptide silkworm C DNA from Bombyx mori and produced recombinant protein by using insect baculovirus expression vector system and antibacterial activity against gram negative bacteria as well as gram positive bacteria. The purpose of the present invention is to provide such antibacterial peptides for the production of disease-resistant transgenic plants, biopesticides and new biological materials.

이하, 본 발명은 상세히 설명하면 다음과 같다.Hereinafter, the present invention will be described in detail.

[요약][summary]

본 발명은 집누에로부터 분리된 새로운 항세균성 유전자 누에신의CDNA와 그CDNA로부터 연역된 아미노산 서열에 관한 것으로 1997년 6월 29일 GenBank에 새로운 유전자로 판명되어 등록번호 AF005384로 등록되었다.The present invention has been found to be related to the amino acid sequence deduced from the new anti-bacterial gene silkworm God C DNA and the DNA separated from the C jipnue a new gene on June 29, 1997 was registered as GenBank Registration No. AF005384.

본 발명에서는 염기서열 및 아미노산 서열을 나타내기 위해 표준 단일자를 사용하며 이들 약어의 의미는 표준 생화학 교재 및 분자 생물학 실험서, 예를 들면 문헌(Lenininger, Principles of Biochemistry, Worth Publishers Inc., ANew Uo가, pp96, 789, 1984 : Sambrook, J. et al., Molecular Cloning, A Laboratory MANUALS, cold Harbor Laboratory Press, N. Y., PP174-184, 1989)에서 찾을 수 있다.In the present invention, standard single characters are used to represent nucleotide sequences and amino acid sequences, and the meanings of these abbreviations are standard biochemistry textbooks and molecular biology experiments, such as Leninginger, Principles of Biochemistry, Worth Publishers Inc., ANew Uo. , pp96, 789, 1984: Sambrook, J. et al., Molecular Cloning, A Laboratory MANUALS, cold Harbor Laboratory Press, NY, PP174-184, 1989).

[기탁][submission]

Baculovirus vAc-nuecin 특허절차의 목적을 위한 미생물 기탁의 국제적 인식에 대한 부다페스트 조약 및 조약하에 공표된 규정하에, 생명공학 연구서(대한민국 대전시소재)(KRIBB)에 기탁되어 있다. 상기 발현 전이 벡터 샘플은 상기 조약에 관련된 특허법 시행령 제4조의 규정에 따라 이들을 받을 권한이 법적으로 주어진 산업재산권 관련 관청(특허청) 및 개인에게 구입가능하거나 가능할 것이다.It is deposited in the Biotechnology Research (KRIBB) (KRIBB) under the regulations published under the Budapest Treaty and Treaty on the International Recognition of Microbial Deposits for the purpose of the Baculovirus vAc-nuecin Patent Procedure. The expression transfer vector sample may be available or available to industrial property authorities and the individual who is legally authorized to receive them under the provisions of Article 4 of the Enforcement Decree of the Patent Act relating to the Treaty.

기탁물에 대한 KRIBB 기탁번호 및 기탁날짜는 다음과 같다.The KRIBB accession numbers and deposit dates for the deposits are as follows:

Figure kpo00001
Figure kpo00001

[발명의 요약][Summary of invention]

또한 본 발명은 상기CDNA를 포함하여 재조합 베큘로바이러스 발현 전이 벡터 및 이에 의하여 형질전환된 재조합 베큘로바이러에 관한 것으로, 그 예로서 전이벡터 pBacPAK8-nuecin 및 그에 의해 형질전환된 재조합 베큘로바이러스 vAc-nuecin을 들 수 있다.The present invention also relates to a recombinant baculovirus expression transfer vector and a recombinant baculovirus transformed thereby, including the C DNA. As an example, the transition vector pBacPAK8-nuecin and the recombinant baculovirus vAc transformed thereby are provided. -nuecin.

본 발명에서는 상기 형질전환된 재조합 베큘로바이러스 vAc-nuencin을 곤충세포주(Spodoptera frugiperda 9)에 감염시킴으로서 재조합 단백질 누에신은 발현되어 곤충세포주에서 배양액으로 성숙된 형태의 누에신으로 분비된 성숙 누에신을 들 수 있다.In the present invention, by infecting the transformed recombinant baculovirus vAc-nuencin to the insect cell line (Spodoptera frugiperda 9), the recombinant protein silkworm is expressed and mature silkworms secreted into the silkworm form of maturation as a culture medium in the insect cell line. have.

본 발명에서는 상기CDNA에 의해 발현된 재조합 단백질 누에신의 항세균 활성은 그람 음성 세균인 E. coli, Erwinia chrysantuemi, Xanthomonas campestrispv. oryzae, Xanthomonas campertris pv. citri와 그람 양성 세균인 Bacillus thuringiensis, Bacillus megaterium, Bacillus thuringiensis kurstaki, Bacillus subtilis, Staphylococcus aureus에서 검정하였다. 본 발명은 하기 실시예에 의해 보다 구체적으로 설명한다.In the present invention, the antibacterial activity of the recombinant protein silkworm expressed by the C DNA is Gram-negative bacteria E. coli, Erwinia chrysantuemi, Xanthomonas campestris pv. oryzae, Xanthomonas campertris pv. Citri and gram positive bacteria Bacillus thuringiensis, Bacillus megaterium, Bacillus thuringiensis kurstaki, Bacillus subtilis and Staphylococcus aureus were tested. The invention is illustrated in more detail by the following examples.

[발명의 설명][Description of the Invention]

[실시예 1]Example 1

[누에신의CDNA 크로닝과 염기서열 및 아미노산 서열 분석][ C DNA Cloning and Nucleotide Sequence and Amino Acid Sequence Analysis of Silkworm]

대수기의 E. coli K12(4×106세포/유충)를 5령 유충 체강에 주입한 후 8시간 경과한 누에를 사용하여 면역 유도 누에CDNA 유존자 은행을 제작하고 정상 누에에 비해 발현량이 증가하는 면역 유도 누에 유전자의 선발을 차별화 선별(differential screening)방법 (Hoog et al., Nuclein Acids Res. 19, 6123-6127, 1991)에 의해 수행하였다. 차별화 선별된CDNA 클론의 염기서열을 분석하기 위해 엑소/멍빈 누클리에즈 (Exo/Mung bean nuclease) 결실 키트(Pronega사 제품)을 이용하여 결실 셋트를 작성하고, 염기서열 분석은 디데옥시쇄 종결 (dideoxy chain termination) 방법 (Sanger et al., Proc. Natl. Acad. Sci U.S.A., 74, 5463-5467, 1997)에 의해 시쿼네이즈 버전 2.0 키트 (Sequenase version 2.0 kit, United States Biochmical사 제품)로 실시하였다. 약 0.5~1.0㎍의 단선 DNA를 1.5 ㎕ T3 프라이머 (Stratagene사 제품, 5′-AATTAACCCTCACTAAAGGG-3′, 20-mer, 3.125 ng/㎕)와 2.0㎕ 5X시퀀싱효소 완충액을 넣고 70℃에서 2분간 변성 후 프라이머와 주형 DNA가 결합될 수 있도록 35℃이하로 온도를 서서히 낮춰 주었다. 그리고, 2.0 ㎕ dGTP (혹은 7-deaza-dGTP, dITP)표식 혼합물과 1.0㎕ 0.1MDTT(dithiothreitol), 0.5㎕[α-35S]dATP (10 mCi/㎖) 혹은 [α-32P]dATP (10 mCi/㎖)와 2.8유니트 (U)의 시퀸싱효소를 넣고, 상온에서 반응시켰다. 상기 방법으로 수행한 반응물을 ddGTP, ddAPT, ddTTP, ddCTP가 들어있는 정지 혼합액에 각각 3.5㎕씩 분주하여, 37℃에서 5분간 종결 반응시켰다. 그리고, 여기에 4.0㎕의 정지완충액을 넣고 염기서열 분석용 젤에 전개하여 염기서열을 결정하였고, 그 결과를 제1도에 나타내었다.After 8 hours of injection of E. coli K12 (4 × 10 6 cells / larva) in logarithmic phase into the larval cavity of the larvae, an immuno-induced silkworm C DNA-rich bank was produced using silkworms. Selection of increasing immune-induced silkworm genes was performed by differential screening (Hoog et al., Nuclein Acids Res. 19, 6123-6127, 1991). In order to analyze the sequencing of the differentially selected C DNA clones, a deletion set was prepared using the Exo / Mung bean nuclease deletion kit (pronega), and the sequencing analysis was completed with the dideoxy chain termination. (dideoxy chain termination) method (Sangenase version 2.0 kit, manufactured by United States Biochmical) by the method (Sanger et al., Proc. Natl. Acad. Sci USA, 74, 5463-5467, 1997). It was. Denature the 0.5-1.0 μg single stranded DNA with 1.5 μl T3 primer (Stratagene, 5′-AATTAACCCTCACTAAAGGG-3 ′, 20-mer, 3.125 ng / μl) and 2.0 μl 5X sequencing enzyme buffer at 70 ° C. for 2 minutes. Afterwards, the temperature was slowly lowered to below 35 ° C. so that the primer and template DNA could be combined. And 2.0 μl dGTP (or 7-deaza-dGTP, dITP) labeling mixture with 1.0 μl 0.1MDTT (dithiothreitol), 0.5 μl [α- 35 S] dATP (10 mCi / ml) or [α- 32 P] dATP ( 10 mCi / ml) and 2.8 units (U) of sequencing enzyme were added and reacted at room temperature. The reaction product carried out by the above method was dispensed in 3.5 ㎕ each of the ddGTP, ddAPT, ddTTP, ddCTP containing a still mixture, and terminated for 5 minutes at 37 ℃. Then, 4.0 μl of stop buffer was added to the gel for sequencing to determine the nucleotide sequence, and the results are shown in FIG. 1.

제1도에 나타난 바와 같이, 면역유도 후 발현량이 증가하는 누에신 (Nuecin)유전자를 선발하고 전체염기서열 결정 결과, 이CDNA는 전체 크기가 852 bp이며, 35번째 염기에서 개시되어 679 위치에서 종결되는 암호화 영역 (open reading frame)을 가지고 있고, 812번째 위치에 잠정 전사 종결 신호인 ‘AATAAA’가 존재함을 확인하였다. 제1도에 나타난 염기서열을 데이터베이스 검색에 의해 새로운 항세균성 단백질 유전자 임이 판명되었다. 제1도에서 왼쪽 말단의 세로로 나열한 숫자는 염기의 순서를 나타낸 것이다.As shown in FIG. 1, after selection of the Nuecin gene with increased expression after immuno-induction, the total nucleotide sequence was determined, and this C DNA had a total size of 852 bp and was initiated at the 35th base at the 679 position. It has an open reading frame and it is confirmed that there is a provisional transcription termination signal 'AATAAA' at the 812th position. The base sequence shown in FIG. 1 was found to be a new antibacterial protein gene by database search. In Fig. 1, the vertically arranged numbers at the left ends indicate the order of bases.

상기 결정된CDNA의 염기서열에 의해 아미노산 서열을 연역하였고, 그 결과를 제2도에 나타내었다.The amino acid sequence was deduced by the base sequence of the determined C DNA, and the results are shown in FIG.

제2도에서 나타난 바와 같이 누에신CDNA의 염기서열에 의해 214개의 아미노산을 연역하였다. 또한 제2도에서 왼쪽 말단의 새로로 나열한 숫자는 아미노산의 순서를 나타낸 것이다.As shown in FIG. 2, 214 amino acids were deduced by the base sequence of silkworm C DNA. Also, in FIG. 2, the newly listed numbers at the left ends indicate the order of amino acids.

[실시예 2]Example 2

[누에신CDNA를 포함하는 재조합 베큘로바이러스 제작][Recombinant baculovirus production comprising silkworm C DNA]

상기 실시예 1에서 염기서열이 결정된 누에신CDNA의 재조합 단백질을 생산하기 위하여 누에신 유전자의 해독 개시 코돈을 포함하는 5′ -프라이머 (5′-CGGGATCCATGTCCAAGAG -3′, 19-mer)와 해독 종결 신호를 포함하는 3′ -프라이머(5′-CGGAATTCTTAGAATTCG-3′, 22-mer)를 합성하여 암호화 영역을 포함하는 DNA 절편을 증폭시킨후, pGEMT 벡터 (Promega사 제품)에 삽입하였으며, 이 재조합 플라스미드를 pGEMT-nuecin으로 명명하였다. PGEMT-nuencin의 BamHl/EcoRl DNA 절편을 pBacPAK8(Clontech사 제품)의 BamHl/EcoRl 위치에 삽입하여 재조합 베큘로바이러스 전이벡터 pBacPAK8-nuecin을 작성하였다. 그 모식도는 제3도에 나타내었다.5′-primer (5′-CGGGATCCATGTCCAAGAG-3 ′, 19-mer) containing the translation start codon of the silkworm gene to produce a recombinant protein of silkworm C DNA having the nucleotide sequence determined in Example 1 above A 3′-primer containing a signal (5′-CGGAATTCTTAGAATTCG-3 ′, 22-mer) was synthesized to amplify the DNA fragment containing the coding region, and then inserted into a pGEMT vector (promega), and the recombinant plasmid Was named pGEMT-nuecin. The BamHl / EcoRl DNA fragment of PGEMT-nuencin was inserted at the BamHl / EcoRl position of pBacPAK8 (Clontech) to prepare a recombinant baculovirus transfer vector pBacPAK8-nuecin. The schematic is shown in FIG.

누에신 유전자가 도입된 재조합 바이러스를 생산하기 위해, 상기 제3도에 나타난 재조합 전이벡터 (pBacPAK8-nuecin)를 혼합하고 리포펙틴(lipofectin, Gibco사 제품)을 동량 첨가하여 상온에서 15분 반응시켰다. 그리고 1.0×106개의 Sf9 세포주를 포함하고 있는 35㎟ 세포 배양용 접시에 상기 혼합물을 접종하여 27℃에서 5분간 트렌스펙션하고, 새 배양액으로 교체한후 27℃에서 5일간 배양하였다.In order to produce a recombinant virus into which the silkworm gene was introduced, the recombinant transfer vector (pBacPAK8-nuecin) shown in FIG. 3 was mixed, and the same amount of lipofectin (lipofectin, manufactured by Gibco) was added and reacted at room temperature for 15 minutes. The mixture was inoculated into a 35 mm 2 cell culture dish containing 1.0 × 10 6 Sf9 cell lines, transfected at 27 ° C. for 5 minutes, replaced with fresh culture solution, and cultured at 27 ° C. for 5 days.

재조합 바이러스(vAc-nuecin)의 선발은 플라크 검정법(Summers & Smith, Texas Agriculture Experiment Station, Billetin No. 1555, 1987)으로 행하였다. 곤충 세포의 배양액을 10-4~10-8으로 한계희석하여 1.5×106세포에 접종한 후, 최종농도 120㎕/㎖의 엑스-갤 (X-gal)이 포함된 저온 용해 아가로스 (FMC제품)를 도말하고, 27℃에서 배양하면서 엑스-갤로 염색되지 않는 플라크의 재조합 바이러스를 선발하였다. 선발된 재조합 바이러스는 재접종하여 증식시켰다. 그 재조합 바이러스의 누에신CDNA 포함 여부의 확인은 재조합 바이러스의 DNA를 분리하여 서던블랏(Southern blot) 분석 방법으로 하였다.The selection of recombinant virus (vAc-nuecin) was performed by plaque assay (Summers & Smith, Texas Agriculture Experiment Station, Billetin No. 1555, 1987). Incubate the culture medium of insect cells with 10 -4 to 10 -8 marginal dilution and inoculate 1.5 × 10 6 cells, and then cryolytic agarose (FMC) containing X-gal at a final concentration of 120 μl / ml. Product) and recombinant viruses of plaques that were not stained with ex-gal were selected while incubating at 27 ° C. The selected recombinant virus was reinoculated and propagated. Confirmation of whether the recombinant virus contained silkworm C DNA was performed by Southern blot analysis by separating the DNA of the recombinant virus.

재조합 바이러스를 접종한 세포 배양액을 2,000rpm, 10분간 원심한 후 그 상청액을 다시 30,000 rpm, 1시간 동안 원심하여 침전물을 수집하였다. 그리고, 침전물에 SDS 1%, 프로테인에이즈 케이 (proteinase K)를 0.5 ㎎/㎖ (Sigma사 제품) 농도가 되도록 첨가하여 37℃에서 4시간 이상 처리하였다. 그 후 동량의 페놀/클로포름-이소아밀알콜(phenol/chloroform-isoamylalcohol, 24:1)을 가하여 혼합하고 15,000rpm으로 5분간 원심분리하여 상청액을 수집하였다. 여기에 2배량의 냉에탄올을 가하고 15,000 rpm으로 15분간 DNA를 침전시키고, 70% 에탄올 세척으로 분리된 재조합 바이러스 DNA를 여러 가지 제한효소를 처리하고 아가로스젤 전기영동한 후, 상온에서 변성용액 (0.5M NaOH, 1.5M NaCl)으로 15분간 침지하고, 중화용액(1M Tris-HCL, pH7.4, 1.5M NaCl)으로 중화시켰다. 중화시킨 겔을 20×SSC용액 (3M NaCl, 0.3M Sodium citrate)으로 나일론 막에 전이시킨 후, UV 크로스링커로 DNA를 고정시켰다. 처리된 막을 바이오틴 (biotin)표지 누에신CDNA를 탐침으로 반응시킨후, 서던 라이트 케미루미너선트 탐색 시스템 (Southern Light Chemiluminescent Detection System, TROPIX사 제품)으로 확인한 그 결과는 제4도에 나타내었다.The cell cultures inoculated with the recombinant virus were centrifuged at 2,000 rpm for 10 minutes and the supernatant was further centrifuged at 30,000 rpm for 1 hour to collect a precipitate. Then, SDS 1%, proteinase K was added to a concentration of 0.5 mg / ml (manufactured by Sigma) and treated at 37 ° C for at least 4 hours. Then, the same amount of phenol / chloroform-isoamyl alcohol (phenol / chloroform-isoamylalcohol, 24: 1) was added and mixed, and the supernatant was collected by centrifugation at 15,000 rpm for 5 minutes. To this, 2 times of cold ethanol was added, the DNA was precipitated for 15 minutes at 15,000 rpm, and the recombinant viral DNA separated by 70% ethanol washing was treated with various restriction enzymes and subjected to agarose gel electrophoresis. 0.5M NaOH, 1.5M NaCl) was immersed for 15 minutes and neutralized with neutralizing solution (1M Tris-HCL, pH7.4, 1.5M NaCl). The neutralized gel was transferred to nylon membrane with 20 × SSC solution (3M NaCl, 0.3M Sodium citrate), and the DNA was fixed with UV crosslinker. The treated membrane was reacted with a biotin-labeled silkworm C DNA with a probe, and the result was confirmed by Southern Light Chemiluminescent Detection System (manufactured by TROPIX).

제4도에 나타난 바와 같이 제한효소 EcoRl을 처리한 재조합 바이러스 DNA의 경우 약 4.3 kb(레인 2), BamHl을 처리한 경우에는 약 2kb(레인 3), 그리고 BamHl/EcoRl을 처리한 경우에는 약 0.6kb(레인 4)의 누에신CDNA 탐침과 결합한 밴드를 보였다. 그러나 대조구를 사용한 야생형 바이러스 (BacPAK B6)의 DNA에서는 밴드를 확인할 수 없었으므로, 재조합 바이러스는 누에신 유전자를 포함하고 있음을 알 수 있었다.As shown in FIG. 4, about 4.3 kb of recombinant viral DNA treated with restriction enzyme EcoRl (lane 2), about 2 kb (lane 3) treated with BamHl, and about 0.6 kb treated with BamHl / EcoRl. Bands were combined with the silkworm C DNA probe of kb (lane 4). However, since the band was not found in the DNA of the wild-type virus (BacPAK B6) using the control, the recombinant virus was found to contain the silkworm gene.

[실시예 3]Example 3

재조합 베큘로바이러스에 의하여 곤충 세포주에서 재조합 누에신 단백질의 발현 상기 실시예 2에서의 누에신 유전자가 도입된 재조합 바이러스를 곤충 세포주(Spodoptera frugiferda 9)에 감염시키고 재조합 누에신 단백질의 세포내 발현을 확인하기 위해 재조합 바이러스가 감염된 곤충 세포주를 3일간 1일 간격으로 세포를 회수하여 단백직 전기영동(Laemmli, Nature, 227, 680-685, 1970)을 수행하여 재조합 누에신 단백질의 세포내 발현을 확인하였다. 재조합 바이러스가 감염된 세포를 모아서 2,000 rpm에서 10분간 원심분리한 뒤, 침전된 세포를 PBS(phosphate buffered saline)용액으로 2회 세척하고, 2배량의 단백질 시료 용액 (0.0625M Tris-HCI, pH6.8, 2% SDS, 10% glycerol, 5% β-mercaptoethanol, 0.001% brbomophenol blue)을 혼합하였다. 그리고 100℃에서 5분간 가열한 후, 전기영동은 12.5% SDS-폴리아크릴아마이드 젤에서 수행하고, 코마시 브릴리언트 블루 (Coomassie brilliant blue) 로 염색하였다. 그 결과는 제5도에 나타내었다.Expression of Recombinant Silkworm Protein in Insect Cell Line by Recombinant Baculovirus Infected with the insect cell line (Spodoptera frugiferda 9), the recombinant virus with the silkworm gene introduced in Example 2 was identified and confirmed the intracellular expression of the recombinant silkworm protein. In order to check the intracellular expression of recombinant silkworm protein by performing recombinant protein electrophoresis (Laemmli, Nature, 227, 680-685, 1970) by recovering the cells at an insect cell line infected with a recombinant virus every three days. . Recombinant virus-infected cells were collected, centrifuged at 2,000 rpm for 10 minutes, and the precipitated cells were washed twice with PBS (phosphate buffered saline) solution, and twice the protein sample solution (0.0625M Tris-HCI, pH6.8). , 2% SDS, 10% glycerol, 5% β-mercaptoethanol, and 0.001% brbomophenol blue) were mixed. After heating at 100 ° C. for 5 minutes, electrophoresis was performed on 12.5% SDS-polyacrylamide gel and stained with Coomassie brilliant blue. The results are shown in FIG.

제5도에서 나타난 바와 같이, 약 23 kDa의 누에신 밴드는 감염되지 않은 정상세포주 (레인 2)와 야생주 바이러스가 감염된 세포주 (레인 3)에서는 관찰되지 않았지만, 재조합 바이러스가 감염된 세포주에서는 접종 후 1일 (레인 4)이 지난 2일째 (레인 5)와 3일째 (레인 6)에 높은 발현량을 보였다.As shown in Figure 5, a silkworm band of about 23 kDa was not observed in uninfected normal cell lines (lane 2) and wild line virus infected cell lines (lane 3), but in recombinant cell infected cell lines 1 Day (lane 4) showed high expression levels on the 2nd day (lane 5) and 3rd day (lane 6).

[실시예 4]Example 4

[재조합 누에신의 항세균 활성 검정][Antibacterial Activity Assay of Recombinant Silkworms]

상기 실시예 3에서 생산된 재조합 누에신의 항세균 활성을 검정하기 위하여, 재조합 바이러스 (vAc-nuecin)에 의해 감염 후 4일 경과된 세포 배양액 40 ㎖(0.5×106cells/㎖,접종농도 1MOl)을 농축한 후 생장 저지 검정(inhibition zone assay)방법 (Lambert et al., Proc.Natl. Acad. Sci. U.S.A., 86, 262-266, 1989)으로 검정하였다. 멸균 배양용 접시 (87×15 ㎜)에 대수기의 세균 (2×105/㎖)이 포함된 아가 배지 (1% nutrient agar, pH7.2)를 5㎖씩 분주하여 응고시켰다. 여기에 직경 6.1㎜ 여과지 (Whatmann 3MM)를 놓고 각 여과지 당 농축된 세포 배양액 (1.2㎕누에신)을 적하하고 37℃에서 배양한 후, 형성된 생장 억제환 (clear zone)의 크기를 측정하였다. 항세균성 검정을 위한 대상 균주로는 그람 음성 세균 4종 (E. coli, Erwinia chrysantuemi, Xanthomonas camperstris pv. oryzae, Xanthomonas campestris pv. citri)과 그람 양성 세균 5종 (Bacillus thuringiensis, Bacillus megaterium, Bacillus thuringiensis kurstaki, Bacillus subtilis, Stphylococcus aureus)을 사용하였다.In order to assay the antibacterial activity of the recombinant silkworm produced in Example 3, 40 ml (0.5 × 10 6 cells / ml, inoculation concentration 1 MOl) 4 days after infection by recombinant virus (vAc-nuecin) Was concentrated and assayed by an inhibition zone assay (Lambert et al., Proc. Natl. Acad. Sci. USA, 86, 262-266, 1989). 5 ml of agar medium (1% nutrient agar, pH 7.2) containing logarithmic bacteria (2 × 10 5 / ml) was coagulated in a sterile culture dish (87 × 15 mm). A filter cell (Whatmann 3MM) having a diameter of 6.1 mm was placed therein, and concentrated cell culture solution (1.2 μL silkworm) was added dropwise to each filter paper, and cultured at 37 ° C., and then the size of the growth zone formed was measured. Four gram negative bacteria (E. coli, Erwinia chrysantuemi, Xanthomonas camperstris pv. Oryzae, Xanthomonas campestris pv. Citri) and five Gram-positive bacteria (Bacillus thuringiensis, Bacillus megaterium, Bacillus thuringiensis kurstaki) , Bacillus subtilis, Stphylococcus aureus) were used.

그 결과는 표 1에 나타내었다.The results are shown in Table 1.

[표 1]TABLE 1

Figure kpo00002
Figure kpo00002

*항세균 활성은 생장 억제환의 크기에 의하여 다음과 같이 결정하였다. ++, 10~15㎜의 생장억제환 ; +++, 15~20 ㎜의 생장억제환 ; 20㎜ 이상의 생장억제환 ; -는 효과없음을 나타냄.* Antibacterial activity was determined by the size of growth inhibitory ring as follows. ++, growth inhibitory ring of 10-15 mm; +++, growth inhibition ring of 15-20 mm; Growth inhibition ring of 20 mm or more; -Indicates no effect.

표 1에 나타난 바와 같이, 재조합 누에신의 항세균 활성 스펙트럼은 그람 음성 세균의 경우는 혐기성 세균인 Escherichia coli와 Erwinia chrysantuemi에는 항세균 활성이 높았으나, 호기성 세균인 Xanthomonas campestris pv. citri에서는 비교적 활성이 낮았으며, Xanthomonas campestris pv. oryzae에 대한 활성은 관찰되지 않았다. 그람 양성 세균 중에서는 토양과 고초(枯草)에 널리 분포하면서 밥 등 부패의 원인균이 되는 Bacillus subtilis에 대한 활성이 높았다. 그리고, 장독소 (enterotoxin)를 생산하여 식중독을 유발하는 Staphylococcus auresus와 병원성이 없는 Bacillus thuringiensis에서는 활성을 나타내지 않았다.As shown in Table 1, the antibacterial activity spectrum of recombinant silkworm showed high antibacterial activity in the gram-negative bacteria of Escherichia coli and Erwinia chrysantuemi, but the aerobic bacteria Xanthomonas campestris pv. In citri, the activity was relatively low, and Xanthomonas campestris pv. No activity against oryzae was observed. Among the Gram-positive bacteria, Bacillus subtilis, which is widely distributed in soil and gourd, is a cause of decay such as rice. In addition, Staphylococcus auresus, which produces enterotoxin to induce food poisoning, and Bacillus thuringiensis without pathogenicity, did not show activity.

위의 분석 결과로부터, 재조합 누에신은 그람 음성 세균 뿐만 아니라 그람 양성 세균에도 항세균 활성을 가짐으로서 집누에로부터 분리된 누에신CDNA는 기능적이며 지금까지 발표된 집누에로부터 분리된 Bmatt와 그람 음성 세균에만 활성을 나타내는 아타신과는 다른 새로운 유전자 임을 확인하였다.From the above analysis, recombinant silkworm has antibacterial activity to Gram-positive bacteria as well as Gram-positive bacteria, so that silkworm C DNA isolated from houseworms is functional and active only to Bmatt and Gram-negative bacteria isolated from houseworms so far published. It was confirmed that it is a new gene different from atacin.

Claims (6)

하기 아미노산 서열을 갖는 것을 특징으로 하는 집누에로부터 분리된 단백질 암호화하는CDNA C DNA encoding a protein isolated from silkworm, characterized by having the following amino acid sequence
Figure kpo00003
Figure kpo00003
제1항에 있어서, 하기 염기서열을 갖는 것을 특징으로 하는CDNAThe C DNA according to claim 1, which has the following nucleotide sequence
Figure kpo00004
Figure kpo00004
Figure kpo00005
Figure kpo00005
제2항의CDNA를 포함하는 재조합 베큘로바이러스 발현 전이 벡터.Recombinant baculovirus expression transfer vector comprising the C DNA of claim 2. 제3항의 재조합 베큘로바이러스 발현 전이 벡터를 포함하는 재조합 베큘로바이러스.A recombinant baculovirus comprising the recombinant baculovirus expression transfer vector of claim 3. 제4항의 재조합 베큘로바이러스에 의해서 생산된 재조합 누에신 단백질.Recombinant silkworm protein produced by the recombinant baculovirus of claim 4. 제5항의 재조합 누에신 단백질을 유효성분으로 하는 항균성 농약.An antimicrobial pesticide comprising the recombinant silkworm protein of claim 5 as an active ingredient.
KR1019970047219A 1997-09-12 1997-09-12 Nuecin cdna separated from bombyx mori KR100261044B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019970047219A KR100261044B1 (en) 1997-09-12 1997-09-12 Nuecin cdna separated from bombyx mori

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019970047219A KR100261044B1 (en) 1997-09-12 1997-09-12 Nuecin cdna separated from bombyx mori

Publications (2)

Publication Number Publication Date
KR19990025553A KR19990025553A (en) 1999-04-06
KR100261044B1 true KR100261044B1 (en) 2000-07-01

Family

ID=19521273

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019970047219A KR100261044B1 (en) 1997-09-12 1997-09-12 Nuecin cdna separated from bombyx mori

Country Status (1)

Country Link
KR (1) KR100261044B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104212805A (en) * 2013-06-04 2014-12-17 香港理工大学 Bombyx mori antibacterial peptide attacin2 and heterogenous expression and application thereof

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Insect Biochem Mol Biol 1995 Mar, 25(3) *
NCBI, Q26431 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104212805A (en) * 2013-06-04 2014-12-17 香港理工大学 Bombyx mori antibacterial peptide attacin2 and heterogenous expression and application thereof

Also Published As

Publication number Publication date
KR19990025553A (en) 1999-04-06

Similar Documents

Publication Publication Date Title
Casteels et al. Isolation and characterization of abaecin, a major antibacterial response peptide in the honeybee (Apis mellifera)
Zdybicka-Barabas et al. Immune response in the larvae of the black soldier fly Hermetia illucens
EP0299828B1 (en) Bactericidal and/or bacteriostatic peptides, process for their isolation, their production and their applications
AU7751487A (en) Method for introduction of disease and pest resistance into plants and novel genes incorporated into plants which code therefor
US6642203B1 (en) Crustacean antimicrobial peptides
KR101099558B1 (en) Antimicrobial peptide gene and antimicrobial peptide isolated from larvae of swallowtail butterfly
JP2018193375A (en) Silk fibers comprising fusion protein and methods for producing the same
JPH07503845A (en) Peptides effective in killing insects
CN108611352B (en) Poaceae root-knot nematode translation elongation factor Mg-eEF1A and application thereof in preventing and treating plant diseases
KR100261044B1 (en) Nuecin cdna separated from bombyx mori
KR101153455B1 (en) An anti-fungal peptide gene isolated from beetle, Protaetia brevitarsis, larvae ,said anti-fungal peptide and its analogue
KR100790807B1 (en) An anti-bacterial peptide base pairs and an anti-bacterial peptide isolated from dung beetle Copris tripartitus larvae
Postlethwait et al. The antibacterial immune response of the medfly, Ceratitis capitata
CA2221793C (en) Novel antibacterial protein
KR100389143B1 (en) New biopesticide using gene from Erwinia pyrifoliae WT#3, novel pathogen that affects Asian pear trees
RU2325398C2 (en) Antibacterial protein chlamisin b, gene, which is coding it, and system that expresses it
CN110003318B (en) Sebastes pomiferus antibacterial peptide moronecidin and application thereof
KR20190088683A (en) Transgenic silkworms producing recombinant antibacterial adhesive peptide and the method producing the recombinant antibacterial adhesive peptide using the same
CN111748025B (en) Sebastes pomiferous antibacterial peptide LEAP2 and application thereof
KR20000031994A (en) Novel chitin degrading enzyme and gene encoding the protein
KR970006163B1 (en) A new fungus having resistance activity to rice blast disease as well as a segment of dna separated from them
US20040087771A1 (en) Antimicrobial peptides of the family of defensins, polynucleotides encoding said peptides, transformed vectors and organisms containing them
AU613074B2 (en) Bactericidal and/or bacteriostatic peptides, process for their isolation, their production and their applications
KR100252196B1 (en) Recombinant EC-SOD protein and nucleotide sequence coding thereof
KR100264340B1 (en) Antibacterial polypeptide

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
EXPY Expiration of term